What's New in Shock, November 2017?
What's New in Shock, November 2017?
复制标题
2017 年 11 月《震撼》有哪些新内容?
DOI:
10.1097/shk.0000000000000953
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
Karlstad,MichaelD
中科院分区:
文献类型:
--
作者:
Collier,JJason;Burke,SusanJ;Karlstad,MichaelD
The mission of the journal SHOCK is ‘‘to foster and promote multidisciplinary studies, both experimental and clinical in nature, that critically examine the etiology, mechanisms and novel therapeutics of shock-related pathophysiological conditions.’’This month’s issue contains a series of publications, comprising two review articles, five basic science studies, and six clinical studies, which demonstrates the journal’s commitment to the above-stated mission. For the assistance of our readership, each publication is briefly deconstructed in this month’s version of the ‘‘What’s New’’summary format. With injury as a leading cause of death, Liu and Salinas (1) have put forth a review on the use of machine learning as a technological tool to assist trauma centers and other health care providers with an additional resource to enhance the quality of patient care. Machine learning is a branch of the computer science and artificial intelligence research areas where software is designed to assess data that have been input with the goal of improving predictive outcomes due to training the computer to ‘‘learn’’specific trends and patterns. The authors point out that machine learning models could be more objective than other methods of evaluation. However, these methods are in their infancy due to lack of software standardization as well as the need for health care provider training in the use of such methods. Although it is unclear at the present time whether machine learning will be widely accepted in critical care, trauma, and other health care disciplines, this review provides a solid framework from which to begin such discussion. Jensen et al.(2) assembled a cogent and concise description of hydrogen sulfide (H2S) in biological processes, with an emphasis on this molecule during ischemia and its associated pathologies. H2S is a signaling molecule that fits within the ‘‘gasotransmitter’’family, which also includes carbon monoxide and nitric oxide. The authors discuss the endogenous production of H2S with an excellent schematic showing enzymatic synthesis. Signaling, toxicity, catabolism, and proposed mechanisms of action are all covered. An interesting component of this review is the inclusion of the various methodologies used for detection of this molecule, which is informative for both basic research and clinical laboratories. Finally, there is a succinct discussion of the various ways to use H2S as a possible therapeutic strategy for ischemia with a summary of future directions and some of the inherent flaws that exist for measuring H2S.The study by Liu et al.(3) is focused on anaphylaxis-related events on a study population that started with 22,080,199 Taiwanese subjects admitted into care in Taiwan over a 17-year period. Of the 2,289 anaphylactic shock episodes occurring between 2005 and 2012, 2,219 participants met the inclusion criteria for data analysis. The authors parsed the data into subjects admitted for food-related anaphylactic shock or druginduced anaphylactic shock. The data revealed that pharmaceuticals were linked with more fatalities due to anaphylactic shock in Taiwanese subjects. The authors note that there is deviation in clinical indicators of anaphylaxis, as well as variances with diagnostic definitions across clinical platforms. Importantly, this epidemiological study adds essential data and brings attention to this immunological phenomenon. Soussi et al.(4), in the next study, asked the interesting and important clinical question related to the interchangeability of oxygen consumption measurements obtained by two methods commonly used in clinical practice. The accurate measurement of oxygen consumption is important because it is often used to …